Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Delcath grows in preparation for market launch

This article was originally published in Clinica

Executive Summary

Delcath Systems, a company developing a drug delivery system for treating liver cancer, has expanded its management team with the following appointments: effective November 2, Armand "Chuck" Frigon will become vice-president of operations and Agustin Gago will assume the role of executive vice-president of global sales and marketing. John Purpura will join as executive vice-president of regulatory affairs and quality assurance on November 16. The New York company created these new roles as it moves closer to submitting its Delcath PHP system, designed for the regional delivery of melphalan to the liver, to the FDA for approval and initiating international licensing and manufacturing activities. Before joining Delcath, Mr Frigon was general manager of Sterigenics International; Mr Gago was vice-president of international oncology surgery sales at AngioDynamics; and Mr Purpura was most recently head of regulatory affairs, North and Latin America, at E-Z-EM.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044579

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel